STAA Stock - STAAR Surgical Company
Unlock GoAI Insights for STAA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $313.90M | $322.42M | $284.39M | $230.47M | $163.46M |
| Gross Profit | $239.58M | $252.65M | $223.38M | $178.64M | $118.36M |
| Gross Margin | 76.3% | 78.4% | 78.5% | 77.5% | 72.4% |
| Operating Income | $-12,611,000 | $28.10M | $43.80M | $33.34M | $6.77M |
| Net Income | $-20,208,000 | $21.35M | $39.66M | $27.51M | $5.91M |
| Net Margin | -6.4% | 6.6% | 13.9% | 11.9% | 3.6% |
| EPS | $-0.41 | $0.44 | $0.83 | $0.52 | $0.13 |
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Visit WebsiteEarnings History & Surprises
STAAEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Feb 10, 2026 | $0.14 | — | — | — |
Q4 2025 | Nov 5, 2025 | $0.18 | $0.46 | +155.6% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | $-0.56 | $-0.07 | +87.5% | ✓ BEAT |
Q2 2025 | May 7, 2025 | $-0.59 | $-0.52 | +11.9% | ✓ BEAT |
Q1 2025 | Feb 11, 2025 | $0.02 | $-0.50 | -2600.0% | ✗ MISS |
Q4 2024 | Oct 30, 2024 | $0.19 | $0.37 | +94.7% | ✓ BEAT |
Q3 2024 | Aug 7, 2024 | $0.25 | $0.33 | +32.0% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $0.05 | $0.06 | +20.0% | ✓ BEAT |
Q1 2024 | Feb 26, 2024 | $0.19 | $0.24 | +26.3% | ✓ BEAT |
Q4 2023 | Nov 1, 2023 | $0.20 | $0.30 | +50.0% | ✓ BEAT |
Q3 2023 | Aug 2, 2023 | $0.32 | $0.40 | +25.0% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $0.11 | $0.18 | +63.6% | ✓ BEAT |
Q1 2023 | Feb 21, 2023 | $0.05 | $0.12 | +140.0% | ✓ BEAT |
Q4 2022 | Nov 2, 2022 | $0.21 | $0.37 | +76.2% | ✓ BEAT |
Q3 2022 | Aug 10, 2022 | $0.25 | $0.42 | +68.0% | ✓ BEAT |
Q2 2022 | May 4, 2022 | $0.16 | $0.29 | +81.2% | ✓ BEAT |
Q1 2022 | Feb 23, 2022 | $0.16 | $0.19 | +18.8% | ✓ BEAT |
Q4 2021 | Nov 3, 2021 | $0.16 | $0.21 | +31.2% | ✓ BEAT |
Q3 2021 | Aug 4, 2021 | $0.08 | $0.27 | +237.5% | ✓ BEAT |
Latest News
Frequently Asked Questions about STAA
What is STAA's current stock price?
What is the analyst price target for STAA?
What sector is STAAR Surgical Company in?
What is STAA's market cap?
Does STAA pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to STAA for comparison